Operating Expenses
Vertex Pharmaceuticals·Income Statement·34 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total operating expenses | $6.2B | $1.7B | $1.9B | $2.1B | $1.8B | $1.9B | $2B | $1.8B |
| Selling, general and administrative | $372.2M | $371.8M | $377.6M | $396.4M | $424.6M | $445.1M | $487M | $493.7M |
| Stock-Based Compensation Expense | $154.2M | $184.6M | $167.8M | $166.1M | $167.3M | $194.9M | $157.6M | $166.4M |
| Share-Based Compensation Expense | $154.2M | $184.6M | $167.8M | $166.1M | $167.3M | $194.9M | $157.6M | $166.4M |
| Stock-based compensation expense | $154.2M | $184.6M | $167.8M | $166.1M | $167.3M | $194.9M | $157.6M | $166.4M |
| Share-Based Compensation | $154.2M | $184.6M | $167.8M | $166.1M | $167.3M | $194.9M | $157.6M | $166.4M |
| Deferred Rent Expense | -$118.8M | -$123.3M | — | -$191.6M | -$113.8M | -$235.9M | $0 | -$65.3M |
| Depreciation and amortization | $54M | $53.2M | $46.5M | $48.4M | $51.7M | $54M | $55.7M | $55.9M |
| Acquired IPR&D Expense | $4.4B | $15M | $87.5M | $19.8M | $2.2M | $54.5M | $56.5M | $500K |
| Acquired In-Process Research and Development | $4.4B | $15M | $87.5M | $19.8M | $2.2M | $54.5M | $56.5M | $500K |
| Acquired in-process research and development expenses | $4.4B | $15M | $87.5M | $19.8M | $2.2M | $54.5M | $56.5M | $500K |
| Amortization of Finite-Lived Intangible Assets | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | — |
| Amortization expense | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | — |
| Defined Contribution Plan Cost | $13.1M | $13.1M | $13.1M | $15.8M | $15.8M | $15.8M | $15.8M | — |
| Operating Lease Cost | $26M | $26M | $26M | $48.7M | $48.7M | $48.7M | $48.7M | — |
| Defined Contribution Plan Cost | $13.1M | $13.1M | $13.1M | $15.8M | $15.8M | $15.8M | $15.8M | — |
| Finance Lease ROU Asset Amortization | $7.7M | $7.7M | $7.7M | $1.8M | $1.8M | $1.8M | $1.8M | — |
| Total Lease Cost | $50.5M | $50.5M | $50.5M | $64.4M | $64.4M | $64.4M | $64.4M | — |
| Defined Contribution Plan Cost | $13.1M | $13.1M | $13.1M | $15.8M | $15.8M | $15.8M | $15.8M | — |
| Operating Lease Cost | $26M | $26M | $26M | $48.7M | $48.7M | $48.7M | $48.7M | — |
| Total Lease Cost | $50.5M | $50.5M | $50.5M | $64.4M | $64.4M | $64.4M | $64.4M | — |
| Lease Cost | $50.5M | $50.5M | $50.5M | $64.4M | $64.4M | $64.4M | $64.4M | — |
| Operating Lease Cost | $26M | $26M | $26M | $48.7M | $48.7M | $48.7M | $48.7M | — |
| Variable Lease Cost | $10.9M | $10.9M | $10.9M | $12.5M | $12.5M | $12.5M | $12.5M | — |
| Defined Contribution Plan Expense | $13.1M | $13.1M | $13.1M | $15.8M | $15.8M | $15.8M | $15.8M | — |
| Finance Lease ROU Asset Amortization | $7.7M | $7.7M | $7.7M | $1.8M | $1.8M | $1.8M | $1.8M | — |
| Occupancy and equipment | $26M | $26M | $26M | $48.7M | $48.7M | $48.7M | $48.7M | — |
| Other operating expenses | — | — | — | $200K | $200K | $200K | $200K | — |
| Amortization of Right-of-Use Assets | $7.7M | $7.7M | $7.7M | $1.8M | $1.8M | $1.8M | $1.8M | — |
| Variable Lease Expense | $10.9M | $10.9M | $10.9M | $12.5M | $12.5M | $12.5M | $12.5M | — |
| Variable Lease Cost | $10.9M | $10.9M | $10.9M | $12.5M | $12.5M | $12.5M | $12.5M | — |
| Lease Costs | $50.5M | $50.5M | $50.5M | $64.4M | $64.4M | $64.4M | $64.4M | — |
| Operating Lease Cost | $26M | $26M | $26M | $48.7M | $48.7M | $48.7M | $48.7M | — |
| Variable Lease Cost | $10.9M | $10.9M | $10.9M | $12.5M | $12.5M | $12.5M | $12.5M | — |